Meta-analysis of Association Between the +49A/G Polymorphism of Cytotoxic T-Lymphocyte Antigen-4 and Thyroid Associated Ophthalmopathy

References

• Jacobson DL, Gange SJ, Rose NR, Graham NM. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol 1997;84:223–243
   PubMedGoogle Scholar
• Weetman AP. Graves’ disease. N Engl J Med 2000;343:1236–1248
   PubMed Web of Science ®Google Scholar
• Khoo TK, Bahn RS. Pathogenesis of Graves’ ophthalmopathy: the role of autoantibodies. Thyroid 2007;17:1013–1018
   PubMed Web of Science ®Google Scholar
• El-Kaissi S, Frauman AG, Wall JR. Thyroid-associated ophthalmopathy: a practical guide to classification, natural history and management. Intern Med J 2004;34:482–491
   PubMed Web of Science ®Google Scholar
• Yamada M, Li AW, Wall JR. Thyroid-associated ophthalmopathy: clinical features, pathogenesis, and management. Crit Rev Clin Lab Sci 2000;37:523–549
   PubMed Web of Science ®Google Scholar
• Bednarczuk T, Gopinath B, Ploski R, Wall JR. Susceptibility genes in Graves' ophthalmopathy: searching for a needle in a haystack? Clin Endocrinol (Oxf) 2007;67:3–19
   PubMed Web of Science ®Google Scholar
• Vaidya B, Imrie H, Perros P, Young ET, Kelly WF, Carr D, et al. The cytotoxic T lymphocyte antigen-4 is a major Graves' disease locus. Hum Mol Genet 1999;8:1195–1199
   PubMed Web of Science ®Google Scholar
• Brunet JF, Denizot F, Luciani MF, Roux-Dosseto M, Suzan M, Mattei MG, et al. A new member of the immunoglobulin superfamily: CTLA-4. Nature 1997;328: 267–270
   Web of Science ®Google Scholar
• Linsley PS, Brady W, Grosmaire L, Aruffo A, Damle NK, Ledbetter JA, et al. Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin-2 mRNA accumulation. J Exp Med 1991;173:721–730
   PubMed Web of Science ®Google Scholar
• Linsley PS, Brady W, Urnes M, Grosmaire LS, Damle NK, Ledbetter JA. CTLA-4 is a second receptor for the B cell activation antigen B7. J Exp Med 1991;174:561–569
   PubMed Web of Science ®Google Scholar
• Thompson CB, Allison JP. The emerging role of CTLA-4 as an immune attenuator. Immunity 1997;7:445–450
   PubMed Web of Science ®Google Scholar
• Buzzetti R, Nisticò L, Signore A, Cascino I. CTLA-4 and HLA gene susceptibility to thyroid-associated orbitopathy. Lancet 1991;354:1824
   Web of Science ®Google Scholar
• Villanueva R, Inzerillo AM, Tomer Y, Barbesino G, Meltzer M, Concepcion ES. Limited genetic susceptibility to severe Graves' ophthalmopathy: no role for CTLA-4 but evidence for an environmental etiology. Thyroid 2000;10:791–798
   PubMed Web of Science ®Google Scholar
• Park YJ, Chung HK, Park DJ, Kim WB, Kim SW, Koh JJ, et al. Polymorphism in the promoter and exon 1 of the cytotoxic T lymphocyte antigen-4 gene associated with autoimmune thyroid disease in Koreans. Thyroid 2000;10:453–459
   PubMed Web of Science ®Google Scholar
• Allahabadia A, Heward JM, Nithiyananthan R, Gibson SM, Reuser TT, Dodson PM, et al. MHC class II region, CTLA4 gene, and ophthalmopathy in patients with Graves' disease. Lancet 2001;358:984–985
   PubMed Web of Science ®Google Scholar
• Vaidya B, Oakes EJ, Imrie H, Dickinson AJ, Perros P, Kendall-Taylor P, et al. CTLA4 gene and Graves' disease: association of Graves' disease with the CTLA4 exon 1 and intron 1 polymorphisms, but not with the promoter polymorphism. Clin Endocrinol (Oxf) 2003;58:732–735
   PubMed Web of Science ®Google Scholar
• Frydecka I, Daroszewski J, Suwalska K, Zołedziowska M, Tutak A, Slowik M, et al. CTLA-4 (CD152) gene polymorphism at position 49 in exon 1 in Graves' disease in a Polish population of the Lower Silesian region. Arch Immunol Ther Exp (Warsz) 2004;52:369–374
   PubMed Web of Science ®Google Scholar
• Petrone A, Giorgi G, Galgani A, Alemanno I, Corsello SM, Signore A, et al. CT60 single nucleotide polymorphisms of the cytotoxic T-lymphocyte-associated antigen-4 gene region is associated with Graves' disease in an Italian population. Thyroid 2005;15:232–238
   PubMed Web of Science ®Google Scholar
• Shen FX, Wang DW, Quan JX, Jiang L, Zhang HL, Feng WH. Relationship between of thyroid-associated ophthalmopathy and T-lymphocyte-associated antigen-4 gene A/G polymorphism at position 49 in exon 1. J Wenzhou Med College 2005;35:356–358
   Google Scholar
• Zhang Q, Yang YM, Lv XY. Association of Graves' disease and Graves' ophthalmopathy with the polymorphisms in promoter and exon 1 of cytotoxic T lymphocyte associated antigen-4 gene. J Zhejiang Univ Sci B 2006;7:887–891
   PubMedGoogle Scholar
• Han S, Zhang S, Zhang W, Li R, Li Y, Wang Z, et al. CTLA4 polymorphisms and ophthalmopathy in Graves' disease patients: association study and meta-analysis. Hum Immunol 2006;67:618–626
   PubMed Web of Science ®Google Scholar
• Chong KK, Chiang SW, Wong GW, Tam PO, Ng TK, Hu YJ, et al. Association of CTLA-4 and IL-13 gene polymorphisms with Graves' disease and ophthalmopathy in Chinese children. Invest Ophthalmol Vis Sci 2008;49:2409–2415
   PubMed Web of Science ®Google Scholar
• Namo Cury A, Longui CA, Kochi C, Calliari LE, Scalissi N, Salles JE, et al. Graves' disease in Brazilian children and adults: lack of genetic association with CTLA-4 +49A>G polymorphism. Horm Res 2008;70:36–41
   PubMed Web of Science ®Google Scholar
• Esteghamati A, Khalilzadeh O, Mobarra Z, Anvari M, Tahvildari M, Amiri HM, et al. Association of CTLA-4 gene polymorphism with Graves' disease and ophthalmopathy in Iranian patients. Eur J Intern Med 2009;20:424–428
   PubMed Web of Science ®Google Scholar
• Guo ZQ, Chen XM, Wu G, Su M, Jie YL, Wu MF, et al. Association in the polymorphism of cytotoxic T lymphocyte antigen-4 gene and the hereditary susceptibility to Graves’ ophthalmopathy of Han population in western region of Guangdong provience. Modern Immunol 2010;30:151–154
   Google Scholar
• Zaletel K, Krhin B, Gaberscek S, Pirnat E, Hojker S. The influence of the exon 1 polymorphism of the cytotoxic T lymphocyte antigen 4 gene on thyroid antibody production in patients with newly diagnosed Graves' disease. Thyroid 2002;12:373–376
   PubMed Web of Science ®Google Scholar
• Bednarczuk T, Hiromatsu Y, Fukutani T, Jazdzewski K, Miskiewicz P, Osikowska M, et al. Association of cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) gene polymorphism and non-genetic factors with Graves' ophthalmopathy in European and Japanese populations. Eur J Endocrinol 2003;148:13–18
   PubMed Web of Science ®Google Scholar
• Yin X, Latif R, Bahn R, Davies TF. Genetic profiling in Graves' disease: further evidence for lack of a distinct genetic contribution to Graves' ophthalmopathy. Thyroid 2012;22:730–736
   PubMed Web of Science ®Google Scholar
• Vaidya B, Imrie H, Perros P, Dickinson J, McCarthy MI, Kendall-Taylor P, Pearce SH. Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphism confers susceptibility to thyroid associated orbitopathy. Lancet 1994;354:743–744
   Web of Science ®Google Scholar
• Zhang Q, Li M, Du YT, Zhang P, Qiu MC. Relationship between Graves’ ophthalmopathy and polymorphism of cytotoxic T-lymphocyte-associated antigen-4 promoter and exon 1. Chin J Intern Med 1004;43:214–215
   Google Scholar
• Han SZ, Zhang SH, Li R, Zhang WY, Li Y. The common -318C/T polymorphism in the promoter region of CTLA4 gene is associated with reduced risk of ophthalmopathy in Chinese Graves' patients. Int J Immunogenet 2006;33:281–287
   PubMed Web of Science ®Google Scholar
• Khalilzadeh O, Mojazi Amiri H, Tahvildari M, Anvari M, Esteghamati A, Mobarra Z, et al. Pretibial myxedema is associated with polymorphism in exon 1 of CTLA-4 gene in patients with Graves' ophthalmopathy. Arch Dermatol Res 2009;301:719–723
   PubMed Web of Science ®Google Scholar
• Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions Version 5.0.2. The cochrane collaboration. 2008. Available from: http://www.mrc-bsu.cam.ac.uk/cochrane/handbook/ [last accessed 4 Feb 2014]
   Google Scholar
• Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009;339:b2535
   PubMed Web of Science ®Google Scholar
• DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trial 1986;7:177–188
   PubMedGoogle Scholar
• Thakkinstian A, McElduff P, D’Este C, Duffy D, Attia J. A method for meta-analysis of molecular association studies. Stat Med 2005;9:1291–1306
   Web of Science ®Google Scholar
• Egger M, Davey SG, Schn eider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. Br Med J 1997;315:629–634
   PubMed Web of Science ®Google Scholar
• Prabhakar, BS, Bahn, RS, Smith TJ. Current perspective on the pathogenesis of Graves' disease and ophthalmopathy. Endocr Rev 2004;24:802–835
   Web of Science ®Google Scholar
• Burman KD, Baker JR. Immune mechanisms in Graves' disease. Endocr Rev 1995;6:183–232
   Google Scholar
• Khalilzadeh O, Noshad S, Rashidi A, Amirzargar A. Graves' ophthalmopathy: a review of immunogenetics. Curr Genomics 2011;12:564–575
   PubMed Web of Science ®Google Scholar
• Bahn RS. Graves' ophthalmopathy. N Engl J Med 2010;362:726–738
   PubMed Web of Science ®Google Scholar
• Gerding MN, van der Meer JW, Broenink M, Bakker O, Wiersinga WM, Prummel MF. Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy. Clin. Endocrinol (Oxf) 2000;52:267–271
   PubMed Web of Science ®Google Scholar
• Jacobson EM, Tomer Y. The genetic basis of thyroid autoimmunity. Thyroid 2007;17:949–961
   PubMed Web of Science ®Google Scholar
• Prummel MF, Wiersinga WM. Smoking and risk of Graves’ disease. JAMA 1993;269:479–482
   PubMed Web of Science ®Google Scholar
• Thornton J, Kelly SP, Harrison RA, Edwards R. Cigarette smoking and thyroid eye disease: a systematic review. Eye (Lond) 2007;21:1135–1145
   PubMed Web of Science ®Google Scholar
• Hunt PJ, Marshall SE, Weetman AP, Bell JI, Wass JA, Welsh KI. Cytokine gene polymorphisms in autoimmune thyroid disease. J Clin Endocrinol Metab 2000;85:1984–1988
   PubMed Web of Science ®Google Scholar
• Ajjan RA, Weetman AP. New understanding of the role of cytokines in the pathogenesis of Graves' ophthalmopathy. J Endocrinol Invest 2004;27:237–245
   PubMed Web of Science ®Google Scholar
• Fife BT, Bluestone JA. Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways. Immunol Rev 2008;224:166–182
   PubMed Web of Science ®Google Scholar
• Sun T, Hu Z, Shen H, Lin D. Genetic polymorphisms in cytotoxic T-lymphocyte antigen 4 and cancer: the dialectical nature of subtle human immune dysregulation. Cancer Res 2009;69:6011–6014
   PubMed Web of Science ®Google Scholar
• Huber A, Menconi F, Corathers S, Jacobson EM, Tomer Y. Joint genetic susceptibility to type 1 diabetes and autoimmune thyroiditis: from epidemiology to mechanisms. Endocr Rev 2008;29:697–725
   PubMed Web of Science ®Google Scholar
• Bednarczuk T, Gopinath B, Ploski R, Wall JR. Susceptibility genes in Graves’ ophthalmopathy: searching for a needle in a haystack? Chin Endocr 2007;67:3–19
   PubMed Web of Science ®Google Scholar